Doripenem Hydrate丨CAS 364622-82-2

Doripenem Hydrate丨CAS 364622-82-2
Product Introduction:
Catalog No.: SS118294
CAS No.: 364622-82-2
Purity: 98.0% min.
Product Name: Doripenem hydrate
Molecular Formula: C15H24N4O6S2.H2O
Molecular Weight: 438.52
Synonym(s): Doripenem monohydrate
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of doripenem hydrate丨cas 364622-82-2 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications of Doripenem hydrate丨CAS 364622-82-2

 

Appearance

White to Light Yellow Powder

Purity

98.0% min.

Specific Rotation

+32.0° to +40.0°

PH

4.5 to 6.0

Clarity and colour of solution

Y/YG5 max.

Related Substances (HPLC)

Any single impurity: 0.5% max.
Total Impurities: 2.0% max.

Water

4.0% to 5.0%

Residue on Ignition

0.1% max.

Heavy Metal

20 ppm max.

 

Transport Information of Doripenem hydrate丨CAS 364622-82-2

 

Parameter

Specification

UN Number

 

Class

 

Packing Group

 

H.S. Code

 

Stability & Reactivity

The product is chemically stable under standard ambient conditions.

Storage

Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature 2 - 8 °C

Condition to Avoid

 

Package

 

 

 

 

Applications

1. Hospital-Based Antibacterial Therapy

Doripenem hydrate丨CAS 364622-82-2 is used primarily in hospital settings for the treatment of severe bacterial infections, including:

Complicated intra-abdominal infections (cIAI)

Complicated urinary tract infections (cUTI), including pyelonephritis

Nosocomial (hospital-acquired) pneumonia, including ventilator-associated pneumonia (VAP)

2. Multidrug-Resistant Bacterial Infections

Effective against a broad spectrum of Gram-positive and Gram-negative aerobic and anaerobic bacteria, including extended-spectrum β-lactamase (ESBL)-producing organisms.

Often used in patients infected with resistant pathogens, such as Pseudomonas aeruginosa, Enterobacteriaceae, and Acinetobacter spp.

3. Critical Care and ICU Use

Frequently employed in intensive care units (ICUs) due to its rapid bactericidal activity, especially when infections are life-threatening or difficult to treat with other antibiotics.


 

Benefits

1. Broad-Spectrum Activity

Doripenem covers a wider range of bacteria than many other β-lactams, including aerobic and anaerobic Gram-negative and Gram-positive strains.

Particularly valuable when the causative organism is unknown and empirical therapy is required.

2. Stable Against Many β-Lactamases

As a carbapenem, doripenem resists degradation by many β-lactamase enzymes, including ESBLs, making it effective where other penicillins and cephalosporins fail.

3. Low Potential for Seizure Induction

Compared to imipenem, another carbapenem, doripenem has a lower risk of neurotoxicity and is better tolerated in patients with renal dysfunction or CNS disorders.

4. Fast-Acting Bactericidal Mechanism

Inhibits bacterial cell wall synthesis, leading to rapid bacterial killing, which is crucial for serious infections.

5. Convenient Dosing Regimen

Typically administered intravenously every 8 hours, with pharmacokinetics supporting effective blood and tissue concentrations.

Can be adjusted for patients with renal impairment.


 

Conclusion

Doripenem hydrate丨CAS 364622-82-2 is a highly potent carbapenem antibiotic with broad-spectrum efficacy against complex and resistant bacterial infections. It plays a crucial role in hospital and ICU treatment protocols, especially for nosocomial infections and multidrug-resistant pathogens. With its strong β-lactamase stability, favorable safety profile, and rapid bactericidal action, doripenem remains a critical weapon in the fight against life-threatening infections.

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us